Dark

HRTX
Heron Therapeutics, Inc.
stock NASDAQ

At Close

Jun 9, 2026 3:59:31 PM EDT

0.4000USD-10.847%(-0.0492)4,378,448

0.3500Bid 0.4800Ask 0.1300Spread

Pre-market

Jun 9, 2026 9:19:30 AM EDT

0.4557USD+0.463%(+0.0021)7,666

After-hours

Jun 9, 2026 4:52:30 PM EDT

0.4180USD+3.363%(+0.0140)147,043

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

75.71M

CEO

Barry Quart

Headquarters

San Diego, California, USA

Industry

Biotechnology

Last Split

May 25, 20071for4reverse

SRDX DRRX NKTR ACHN LGND PCRX ALKS INSY XLV

HRTX Stats

Avg. Vol. 10 Day

5,427,448

Avg. Vol. 30 Day

3,425,155

Employees

145

Market Cap

75,711,748

Shares Out.

189,279,369

On/Off Exchange

38%/62%

6 Month Beta

2.46

1 Year Beta

2.10

2 Year Beta

1.29

3 Year Beta

1.43

52 Week Low

0.42

52 Week High

2.30

SMA50

0.92

SMA200

1.15

1 Week

-11.11%

1 Month

-66.94%

3 Month

-59.86%

6 Month

-69.93%

1 Year

-81.13%

2 Year

-89.16%

5 Year

-97.29%

Profile

heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.

HRTX Stock Summary

Heron Therapeutics, Inc. (NASDAQ:HRTX) stock price today is $0.4000, and today's volume is 4,378,448. HRTX is down -10.847% today. The 30 day average volume is 3,425,155. HRTX market cap is 75.71M with 189,279,369 shares outstanding.

.dark-mode .h7JLbx{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .h7JLbx{ color: #333333; background-color: white; border: 2px solid #333333; }HRTXHeron Therapeutics, Inc.stock NASDAQ

HRTX Stock Summary

HRTX
Heron Therapeutics, Inc.
stock NASDAQ